We aspire to be the premier research-intensive biopharmaceutical company. We’re at the forefront of research to deliver innovative health solutions that advance the prevention and …
Dec 31, 2023 · Merck is a global health care company that delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies, and animal health products. …
Learn how Merck has created a legacy of inventing medicines and vaccines and become a leading global biopharmaceutical company over the past 130 years.
Explore current job opportunities at Merck. Learn more about careers in Business Support, Clinical, Engineering, Information Technology, Research & Development, Manufacturing and …
Nov 6, 2024 · Merck’s (NYSE: MRK) Q1 2024 results reflect continued strong growth in oncology and vaccines. Our company announced Q1 worldwide sales of $15.8 billion, an increase of 9% …
Oct 28, 2024 · Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers. October 23, 2024. CDC’S …
Contact information for stockholders and investors is available here. Merck's U.S. headquarters, worldwide office, adverse event, investors, media, supplies and animal health contact …
For information about Merck’s products and services including the reporting of an Adverse Event or Product Quality Complaint with a specific Merck product, please call the Merck National …